Skip to content

Study Details

Testing the Drug Baricitinib in Patients Ages 6 to 18 Years Old with Alopecia Areata

(IRB#: IRB_00166438)

Alopecia Areata is sudden hair loss that often occurs in the hair on a persons head. This study will test a drug called Baricitinib to treat patients ages 6 to 18 years old with this disease. The drug has already been approved for adults with this condition. The study wants to see if the drug will help the specific age of patients with this disease. Participants will be treated with Baricitinib. The drug is taken as a liquid or a swallowed pill. Being in the study requires up to 18 study visits at the clinic over 2.5 years. Medical tests will be done during the study to track the health of participants.


  • All genders
  • Under 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Under 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 6 to 18 years old
  • Diagnosis of Alopecia Areata
  • Able to stop certain treatments for Alopecia Areata
  • Able to attend in person at the study clinic

Exclusion Criteria

  • Other active skin conditions that may cause hair loss
  • Serious medical condition
  • History of blood clots in the legs or lungs
  • Certain types of heart disease
  • Currently have or have had a recent serious infection

Will I be paid for my time?


For more information contact:

Sean Wentland


IRB#: IRB_00166438

PI: Jamie Rhoads


Approval Date: 2023-12-13 07:00:00

Specialties: Dermatology

Last Updated: 6/8/23